Anti-Müllerian hormone (AMH) has become one of the most commonly discussed fertility markers in recent years. If you’re over 35 and have had a fertility workup—or even just a general conversation with an OB/GYN about future family planning—there’s a good chance AMH has come up.
Understanding what AMH measures, what it does and doesn’t tell you, and why a single number should never be the sole determinant of your fertility picture can make these conversations significantly less anxiety-inducing. This overview reflects current research on AMH and aims to provide context rather than conclusions.
What Research Shows About AMH and Ovarian Reserve
AMH is a hormone produced by granulosa cells in the ovarian follicles. Research has established AMH as a marker of ovarian reserve—essentially, an estimate of the remaining pool of eggs (or ovarian follicles) at a given point in time. Higher AMH levels are generally associated with a larger follicle pool; lower levels are associated with a smaller pool.
According to studies in reproductive medicine and information from the National Institute of Child Health and Human Development, AMH levels naturally decline with age, reflecting the natural reduction in ovarian reserve that occurs throughout the reproductive years. This decline tends to be gradual across the 30s and may accelerate somewhat in the late 30s and into the 40s—though the timing and pace vary considerably among individuals.
What AMH Does and Does Not Tell You
This is perhaps the most important context to understand around AMH testing. AMH is a measure of ovarian reserve—the quantity of eggs remaining—but it is not a direct measure of egg quality, and quantity and quality are two distinct dimensions of fertility.
What AMH Measures
AMH reflects the approximate number of developing follicles currently in the ovarian pool. A lower AMH suggests fewer eggs in reserve. This information can be relevant for planning (especially for women considering egg freezing or IVF) and for helping a reproductive specialist understand the likely response to ovarian stimulation.
What AMH Does Not Measure
AMH does not measure egg quality, the likelihood of conceiving in any given cycle, or the overall probability of eventual pregnancy. Research has shown that women with lower AMH levels can and do conceive naturally, and that AMH alone is a poor predictor of conception outcomes in women trying to conceive without assisted reproduction. If you’ve received a lower-than-expected AMH result, understanding that this does not foreclose natural conception is important context.
For women thinking about what fertility testing after 35 actually involves, keeping AMH in proper perspective as one marker among several is worth emphasizing from the start.
Interpreting AMH Numbers in Context
AMH results are typically reported in ng/mL (nanograms per milliliter) or pmol/L (picomoles per liter), and reference ranges vary among laboratories. What is considered “within range” for a 38-year-old may differ from what’s expected at 32 or 44, because age-adjusted interpretation is essential.
The Importance of Age-Adjusted Interpretation
A number that appears low relative to a general reference range may actually be within a typical range for a woman’s specific age. This is why comparing your AMH to a friend’s, or to a population average without age context, can be misleading. A reproductive endocrinologist or fertility specialist is best positioned to interpret AMH results in the context of your full clinical picture—including age, cycle regularity, antral follicle count on ultrasound, and other hormone levels.
AMH as One Piece of a Broader Assessment
Ovarian reserve assessment typically includes AMH, antral follicle count (AFC) via transvaginal ultrasound, and sometimes basal FSH and estradiol levels. Together, these markers provide a more complete picture than any single test alone. FSH (follicle-stimulating hormone) and AFC can corroborate or add nuance to AMH results, and their combination informs a reproductive specialist’s understanding of ovarian reserve more fully.
AMH and Family Planning Decisions
For women who are not currently trying to conceive but are thinking about future family building, AMH testing is sometimes offered as a way to gain a general sense of ovarian reserve. However, the research on using AMH for “fertility prediction” in otherwise fertile women is more limited than its use in clinical fertility evaluation.
What a lower AMH result in this context may suggest is that the window for natural conception or egg cryopreservation may be somewhat shorter than average—but it does not predict inability to conceive, nor does it provide a precise timeline. Discussing the relevance of AMH testing for your specific situation and goals with a gynecologist or reproductive endocrinologist is the most useful path to interpreting any result you receive.
For women also navigating information about egg freezing considerations after 35, AMH is one of the key markers that fertility clinics use to assess candidacy and expected response to stimulation.
Living With Uncertainty in the AMH Conversation
It is worth acknowledging that receiving an AMH result—particularly a lower-than-expected one—can be emotionally difficult. Many women describe feeling shocked or discouraged by a number that they immediately associate with diminished chances of having a family. This emotional response is understandable and valid.
But context matters: AMH is one data point, not a destiny. Research consistently shows that individual outcomes vary widely, that conception is possible across a range of AMH values, and that AMH alone should not drive major decisions without a fuller clinical evaluation. If you’ve received a result that has caused distress, speaking with a reproductive endocrinologist for a thorough interpretation—and potentially a counselor experienced in reproductive health—can help provide both clarity and support.
Frequently Asked Questions
Can I improve my AMH levels?
AMH reflects the current follicle pool, which naturally declines with age and cannot be meaningfully increased through lifestyle changes. Research does not support the idea that supplements, diet, or other interventions can substantially raise AMH. What can be supported through healthy habits is overall reproductive health, which involves many factors beyond AMH.
When should I get my AMH tested?
AMH can be measured at any point in the menstrual cycle (unlike some hormones that are cycle-dependent), which makes it a convenient test to include in a general reproductive health evaluation. The decision of when to test—and whether to test—is best made in conversation with a healthcare provider based on your individual circumstances and goals.
Is a low AMH a guarantee that I can’t get pregnant naturally?
No. Research has documented natural conceptions in women with low AMH, and the test does not predict individual conception outcomes. It provides information about the size of the ovarian reserve, not the quality of individual eggs or the overall likelihood of conception in any specific situation.
How often should AMH be tested?
There is no universal standard for repeat testing frequency. Some providers retest annually for women who are monitoring ovarian reserve over time; others focus on a single assessment when relevant for clinical decision-making. Your provider can advise on what makes sense for your situation.
Key Takeaways
- AMH reflects ovarian reserve—the estimated size of the follicle pool—but does not directly measure egg quality or predict individual conception outcomes.
- AMH should always be interpreted in an age-adjusted context and alongside other ovarian reserve markers (AFC, FSH), not as a standalone number.
- Lower AMH does not mean inability to conceive; research has documented natural pregnancies across a wide range of AMH values.
- For the most meaningful interpretation of any AMH result, consultation with a reproductive endocrinologist is strongly recommended.
Medical Disclaimer
This content is for informational purposes only and does not constitute medical advice. Individual health situations vary significantly. Always consult a qualified healthcare provider before making decisions related to your health, fertility, or pregnancy.
About the Author
Emily Carter is a women’s health writer focused on fertility, pregnancy after 35, and sleep changes in midlife. She writes research-informed, non-alarmist content to help women navigate reproductive and hormonal transitions with clarity and confidence.